Education
About Us
Working with TipRanks
Follow Us
Ramm Pharma Corp (TSE:RAMM)
:RAMM
RAMM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)7.12K
Market Cap
C$1.19M
Enterprise ValueN/A
Total Cash (Recent Filing)C$480.44K
Total Debt (Recent Filing)C$197.69K
Price to Earnings (P/E)―
Beta1.57
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding119,389,320
10 Day Avg. Volume18,800
30 Day Avg. Volume7,123
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.19
Price to Sales (P/S)0.00
P/FCF Ratio-0.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ramm Pharma News
PremiumCompany Announcements
RAMM Pharma Explores Sale of Italian Subsidiary Canapar
PremiumCompany Announcements
Ramm Pharma Updates on Legal Dispute Outcome
PremiumCompany Announcements
RAMM Pharma Corp. Awaits Key Litigation Verdict
PremiumCompany Announcements
RAMM Pharma Expands with Botanical SupplementsOptions Prices
Currently, No data available
---
Ownership Overview
22.38% Insiders
―
Mutual Funds
0.01% Other Institutional Investors
77.61% Public Companies and
Individual Investors
RAMM FAQ
What was Ramm Pharma Corp’s price range in the past 12 months?
Ramm Pharma Corp lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.
What is Ramm Pharma Corp’s market cap?
Ramm Pharma Corp’s market cap is C$1.19M.
When is Ramm Pharma Corp’s upcoming earnings report date?
Ramm Pharma Corp’s upcoming earnings report date is Sep 25, 2025 which is in 80 days.
How were Ramm Pharma Corp’s earnings last quarter?
Ramm Pharma Corp released its earnings results on Jun 27, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Ramm Pharma Corp overvalued?
According to Wall Street analysts Ramm Pharma Corp’s price is currently Overvalued.
Does Ramm Pharma Corp pay dividends?
Ramm Pharma Corp does not currently pay dividends.
What is Ramm Pharma Corp’s EPS estimate?
Ramm Pharma Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramm Pharma Corp have?
Ramm Pharma Corp has 119,389,320 shares outstanding.
What happened to Ramm Pharma Corp’s price movement after its last earnings report?
Ramm Pharma Corp reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ramm Pharma Corp?
Currently, no hedge funds are holding shares in TSE:RAMM
Company Description
Ramm Pharma Corp
Ramm Pharma (RAMM) is a pharmaceutical company that specializes in the development and commercialization of cannabinoid-based products. The company operates in the medical, pharmaceutical, and wellness sectors, offering a range of products that include prescription medications, over-the-counter treatments, and wellness supplements. Ramm Pharma focuses on leveraging its expertise in cannabinoid research to provide innovative solutions for various health conditions.